These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32602210)

  • 1. Cyclosporin in dermatology: A practical compendium.
    Amber T; Tabassum S
    Dermatol Ther; 2020 Nov; 33(6):e13934. PubMed ID: 32602210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in Dermatology.
    Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
    Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cyclosporine in dermatology.
    Dehesa L; Abuchar A; Nuno-Gonzalez A; Vitiello M; Kerdel FA
    J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review and update of the clinical uses of cyclosporine in dermatology.
    Groisser DS; Griffiths CE; Ellis CN; Voorhees JJ
    Dermatol Clin; 1991 Oct; 9(4):805-17. PubMed ID: 1934654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine in the treatment of dermatologic disease: an update.
    Lim KK; Su WP; Schroeter AL; Sabers CJ; Abraham RT; Pittelkow MR
    Mayo Clin Proc; 1996 Dec; 71(12):1182-91. PubMed ID: 8945493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V; Griffiths CE
    Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive agents in dermatology.
    Ho VC; Zloty DM
    Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the efficacy and safety of topical cyclosporine in dermatology.
    Sadeghi S; Kalantari Y; Seirafianpour F; Goodarzi A
    Dermatol Ther; 2022 Jun; 35(6):e15490. PubMed ID: 35384191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cyclosporine (CsA) in Immuno-dermatological Conditions.
    Rajagopalan M; Saraswat A; Chandrashekar BS; Dhar S; Dogra S; Tahiliani S; Raj P
    Indian Dermatol Online J; 2022; 13(5):585-599. PubMed ID: 36304637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporin A in the therapy of inflammatory dermatoses].
    Peter RU; Ruzicka T
    Hautarzt; 1992 Nov; 43(11):687-94. PubMed ID: 1468930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the use of ciclosporin in immune-mediated dermatoses.
    Griffiths CE; Katsambas A; Dijkmans BA; Finlay AY; Ho VC; Johnston A; Luger TA; Mrowietz U; Thestrup-Pedersen K
    Br J Dermatol; 2006 Jul; 155 Suppl 2():1-16. PubMed ID: 16774579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of tacrolimus in dermatology].
    Slodownik D; Ingber A
    Harefuah; 2003 Nov; 142(11):770-4, 805. PubMed ID: 14631910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of cyclosporine in dermatology: part I.
    Amor KT; Ryan C; Menter A
    J Am Acad Dermatol; 2010 Dec; 63(6):925-46; quiz 947-8. PubMed ID: 21093659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses.
    Dai A; Kim SJ
    J Am Acad Dermatol; 2024 Feb; 90(2):358-367. PubMed ID: 37307993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients and side effects during cyclosporine therapy for cutaneous disorders.
    Fradin MS; Ellis CN; Voorhees JJ
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1265-73; discussion 1273-5. PubMed ID: 2277134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive agents in dermatology. An update.
    Dutz JP; Ho VC
    Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate in dermatology.
    Liu V; Mackool BT
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
    Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA;
    G Ital Dermatol Venereol; 2014 Oct; 149(5):607-25. PubMed ID: 25213388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
    Behnam SM; Behnam SE; Koo JY
    J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.